These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1540665)

  • 1. Altered ratio of collagen chains in bone of a patient with non-lethal osteogenesis imperfecta.
    Sokolov BP; Sher BM; Hausmann J; Marik I; Deyl Z; Kalinin VN
    Biochim Biophys Acta; 1992 Feb; 1138(2):93-6. PubMed ID: 1540665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
    Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.
    Francis MJ; Williams KJ; Sykes BC; Smith R
    Clin Sci (Lond); 1981 Jun; 60(6):617-23. PubMed ID: 6788428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered relation of two collagen types in osteogenesis imperfecta.
    Sykes B; Francis MJ; Smith R
    N Engl J Med; 1977 May; 296(21):1200-3. PubMed ID: 857159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies.
    van der Rest M; Hayes A; Marie P; Desbarats M; Kaplan P; Glorieux FH
    Am J Med Genet; 1986 Jul; 24(3):433-46. PubMed ID: 3728562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.
    Kirsch E; Glanville RW; Krieg T; Müller P
    Biochem J; 1983 Jun; 211(3):599-603. PubMed ID: 6411063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta.
    Petrovic OM; Miller EJ
    J Clin Invest; 1984 Jun; 73(6):1569-75. PubMed ID: 6427276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
    Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
    Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition, cross-linking and thermal stability of bone and skin collagens in patients with osteogenesis imperfecta.
    Herbage D; Borsali F; Buffevant C; Flandin F; Aguercif M
    Metab Bone Dis Relat Res; 1982; 4(2):95-101. PubMed ID: 6815415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenesis imperfecta (lethal) bones contain types III and V collagens.
    Pope FM; Nicholls AC; Eggleton C; Narcissi P; Hey EN; Parkin JM
    J Clin Pathol; 1980 Jun; 33(6):534-8. PubMed ID: 7400355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
    J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 collagen synthesis by skin fibroblasts from 17 patients with osteogenesis imperfecta type III.
    Pocock AE; Francis MJ; Smith R
    Clin Chim Acta; 1995 Dec; 243(1):53-72. PubMed ID: 8747514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia.
    Royce PM; Blumberg A; Zurbrügg RP; Zimmermann A; Colombo JP; Steinmann B
    Eur J Pediatr; 1988 Aug; 147(6):626-31. PubMed ID: 3181205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of type III collagen in bone from a patient with osteogenesis imperfecta.
    Müller PK; Raisch K; Matzen K; Gay S
    Eur J Pediatr; 1977 Apr; 125(1):29-37. PubMed ID: 858306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta: biochemical studies of bone collagen.
    Fujii K; Tanzer ML
    Clin Orthop Relat Res; 1977 May; (124):271-7. PubMed ID: 598086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.